Spok Holdings, Inc.

NASDAQ:SPOK

Medical - Healthcare Information Services

Healthcare
$10.93 +1.60%

+$0.17 today

Market cap
$228.30M
Beta
0.44
P/E (TTM)
17.2
EPS (TTM)
$0.61
Dividend yield
11.93%
52W Low $9.95High $19.31

Volume 0.18M

Average 0.17M

SPOK Accounts Receivables

Cash effect of the change in amounts owed by customers; growing receivables consume cash.

Spok Holdings, Inc.NASDAQ: SPOK

Accounts Receivables · Q1 FY2026 · quarter ended Mar 2026

Accounts receivables growth accelerates

Q1 FY2026 accounts receivables of $2.47M rose 135.3% year over year, ahead of the -324.4% change in trailing-twelve-month accounts receivables. Sequentially, it fell 2.8% from the prior quarter. Over 3 fiscal years it compounded at +3.6% a year.

Context

  • Accounts receivables amounted to 1.4% of revenue in FY2025, up 1.0 pp from a year earlier.
  • Accounts receivables increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +135.3% holds above the trailing-twelve-month pace of -324.4%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$2.47M-2.8% QoQ
Last fiscal yearDec 2025
-$1.96M-486.4% YoY
LTMMar 2026
-$534K-324.4% YoY
Accounts Receivables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+135.3%——
1 year-486.4%——
3-year CAGR+3.6%——
5-year CAGR——
10-year CAGR——

Accounts Receivables history

USD · from the cash flow

Latest · FY2025
(1.96M) USD
Year-over-year change
-486.4%

Accounts Receivables vs competitors

How SPOK compares with its peers on the latest reported figures

  • Peers report in different currencies, so accounts receivables is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -324.4% is the 9th highest of 11, against a peer median of +7.2%.
  • Accounts receivables amounts to 0.4% of revenue for SPOK, versus a peer median of 1.9%.
SPOK Competitors
Accounts Receivables for SPOK and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CGCCanopy Growth CorporationLTM Mar 2026CA$23.54M CAD+624.8%+60.2%7.5%
SENSSenseonics Holdings, Inc.LTM Mar 2026$11.43M USD+537.2%+141.9%28.1%
DHDefinitive Healthcare Corp.LTM Mar 2026$4.29M USD-67.1%—1.8%
SOPHSOPHiA GENETICS S.A.LTM Mar 2026$3.43M USD-549.9%—4.2%
CERSCerus CorporationLTM Mar 2026$3.19M USD-13.2%-65.0%1.4%
MASS908 Devices Inc.LTM Mar 2026$2.87M USD-1376.9%-66.6%5.0%
VMDViemed Healthcare, Inc.LTM Mar 2026$2.56M USD+32.8%—0.9%
SLPSimulations Plus, Inc.LTM Feb 2026$1.68M USD+27.5%-47.2%2.1%
TBRGTruBridge, Inc.LTM Mar 2026$622K USD-80.6%-37.3%0.2%
SPOKSpok Holdings, Inc.LTM Mar 2026$534K USD-324.4%+3.6%0.4%
NRCNational Research CorporationLTM Mar 2026$494K USD+111.1%-58.3%0.4%
Peer median (excluding SPOK) —+7.2%-47.2%1.9%

Competitors are the stored peer set for SPOK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(22.18M)21.86M15.67M14.97M15.88M
Depreciation & Amortization10.45M3.57M4.5M4.15M3.43M
Deferred Income Tax(5.48M)903K6.38M4.57M5.17M
Stock-Based Compensation7.24M3.83M4.06M4.96M5.01M
Change in Working Capital1.12M(3.63M)(5.37M)(566K)(966K)
Accounts Receivables1.83M(1.76M)2.58M506K(1.96M)
Inventory3.36M0000
Accounts Payables(679K)(2.26M)(5.22M)(1.18M)(1.74M)
Other Working Capital(3.39M)387K(2.73M)112K2.73M
Other Non-Cash Items16.83M(20.07M)950K846K430K
Operating Cash Flow7.97M6.46M26.18M28.92M28.95M
Capital Expenditures(15.24M)(3.78M)(3.42M)(3.21M)(3.75M)
Acquisitions (Net)10.84M(15.03M)000
Purchases of Investments(44.99M)(14.97M)000
Sales of Investments60M30M000
Other Investing Activities(10.84M)15.03M00701K
Investing Cash Flow(225K)11.26M(3.42M)(3.21M)(3.05M)
Debt Repayment00000
Common Stock Issued0000312K
Common Stock Repurchased(1.86M)(1.21M)(1.25M)(2.43M)(2.84M)
Dividends Paid(10.03M)(25.01M)(25.64M)(26.38M)(27.26M)
Other Financing Activities132K0210K272K0
Financing Cash Flow(11.75M)(26.22M)(26.68M)(28.54M)(29.79M)
Effect of Forex Changes(136K)(321K)145K(20K)28K
Net Change in Cash(4.15M)(8.83M)(3.77M)(2.84M)(3.87M)
Free Cash Flow(7.27M)2.68M22.77M25.71M25.2M

Spok Holdings, Inc.

NASDAQ:SPOK

Intrinsic Alpha fair value

Locked

Current Price

$10.93

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.